SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-19-021751
Filing Date
2019-03-29
Accepted
2019-03-29 16:28:22
Documents
1
Period of Report
2019-02-07

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4407
  Complete submission text file 0001209191-19-021751.txt   5810
Mailing Address C/O CREDIT SUISSE 1ST BOSTON PRV EQY 11 MADISON AVENUE NEW YORK NY 10010
Business Address
HUNT RONALD (Reporting) CIK: 0001247851 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38800 | Film No.: 19716830

Mailing Address 4000 SHORELINE CT #250 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE CT #250 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Issuer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)